Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 0.84 | 0.04 | 15.06 |
| 6M | -4.59 | 1.53 | 121.06 |
| 1Y | 1.36 | 4.85 | 235.06 |
| 3Y | 0.00 | 14.35 | 369.26 |
Nippon India Innovation Fund Growth managed by Nippon India Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,778 Crore. The fund benchmarks its performance against the NIfty 500 Total Return while maintaining an expense ratio of 2.46. Under the expert guidance of Vinay Sharma ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Vinay Sharma holds MBA - IIM Calcutta, CFA - AIMR USA. His past experience are, ICICI Prudential Asset Management Limited - PMS Fund Manager - (January 2012 to April 06, 2014). ICICI Prudential Asset Management Limited - Equity Analyst - (February 2010 to June 2011). AIG Global Asset Management India Limited - Equity Analyst - (February 2007 to January 2010). J.P.Morgan India Private Limited - Equity Analyst (December 2004 to January 2007).
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund Growth | 0 | 2158.58 CR | 2.88 |
| Motilal Oswal Business Cycle Fund Growth | 0 | 1570.51 CR | 2.13 |
| Nippon India Innovation Fund Growth | 0 | 2778.33 CR | 2.46 |
| HDFC Defence Fund Growth | 5 | 9123.61 CR | 1.79 |
| Nippon India Taiwan Equity Fund Growth | 3 | 1138.67 CR | 2.17 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundHDFC Pharma and Healthcare Fund Growth | 18.7376 | 0 |
| This FundMotilal Oswal Business Cycle Fund Growth | -9.6825 | 0 |
| This FundNippon India Innovation Fund Growth | 1.3616 | 0 |
| This FundHDFC Defence Fund Growth | 10.2011 | 176.5488 |
| This FundNippon India Taiwan Equity Fund Growth | 230.4848 | 350.1695 |